ARQ 621

· ArQule, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for ARQ 621, covering 2011-10-19 to 2011-10-19. Get the full timeline:

Most recent: Clinical Trial Update: Dose Escalation Study of ARQ 621 in Adult Patients With Metastatic Solid Tumors and Hematologic Malignancies [Phase 1]

See pricing